Researchers at Johns Hopkins University have demonstrated a surgical robot capable of autonomously completing an entire gallbladder removal on ex-vivo pig organs. The system, named Surgical Robot Transformer-Hierarchy (SRT-H), was trained on about 17 hours of video covering 16,000 surgeon motions and uses a two-tier artificial-intelligence model to translate endoscopic images into plain-language instructions and then into precise tool movements.

Read more

In a pioneering medical procedure, Dr. Vipul Patel, based in Florida, successfully performed robotic prostate surgery on a 67-year-old patient located in Luanda, Angola, approximately 11,265 kilometers away. This operation, conducted as part of a human clinical trial approved by the U.S. Food and Drug Administration, marks the first transcontinental telesurgery of its kind in Africa.

The procedure utilized advanced robotic technology with no perceptible delay, demonstrating the potential to transform global healthcare access by enabling remote surgeries across vast distances. The patient, Fernando da Silva, was diagnosed with prostate cancer and discharged three days after the operation. This breakthrough follows recent developments in remote robotic surgeries, including Chinese surgeons performing satellite-powered liver surgeries over 5,000 kilometers away, highlighting rapid advancements in telesurgery facilitated by robotics and satellite communication technologies. Additionally, autonomous surgical robots trained with artificial intelligence have achieved 100% accuracy in complex procedures on lifelike models, signaling further innovation in surgical robotics.

In a pioneering medical procedure, Dr. Vipul Patel, based in Florida, successfully performed robotic prostate surgery on a patient located in Angola, approximately 11,265 kilometers away. This transcontinental telesurgery, conducted as part of a human clinical trial approved by the U.S. Food and Drug Administration, involved advanced robotic technology that enabled the operation with no perceptible delay.

The patient, Fernando da Silva, a 67-year-old man diagnosed with prostate cancer, was discharged three days after the procedure. This surgery marks the first of its kind globally and represents a potential breakthrough in expanding healthcare access through remote robotic-assisted surgeries. Separately, Chinese doctors have also recently achieved success in performing remote liver surgeries over a distance of 5,000 kilometers using satellite communication technology, demonstrating advancements in telesurgery beyond terrestrial networks. Healthcare experts are advocating for uniform insurance coverage for robotic-assisted surgeries to support these emerging medical technologies.

In a pioneering medical procedure, Dr. Vipul Patel, an Orlando-based surgeon, successfully performed robotic prostate surgery on a 67-year-old patient located in Angola, approximately 11,265 kilometers away. This transcontinental telesurgery, conducted under a human clinical trial approved by the U.S. Food and Drug Administration, marks the first instance of such a remote operation in Africa.

The patient, Fernando da Silva, was diagnosed with prostate cancer and underwent the procedure using advanced robotic technology that allowed for real-time control without delay. The surgery was completed successfully, and the patient was discharged after three days. This breakthrough demonstrates the potential of robotic telesurgery to expand access to specialized healthcare across global distances, potentially revolutionizing medical treatment in regions with limited surgical resources.

A Florida surgeon has completed what hospital officials say is the world’s longest-distance robotic operation, removing the prostate of a cancer patient in Luanda, Angola, from a console in Orlando, some 11,000 kilometres away. The 14 June procedure is the first remote surgery performed in Africa and is part of a U.S. Food and Drug Administration-approved clinical trial examining transcontinental telesurgery.

Read more

The National Health Service (NHS) in the UK is set to significantly expand the use of robotic-assisted surgery over the next decade, with projections indicating that 90% of all keyhole surgeries will be robot-assisted by 2035. This shift aims to reduce waiting times for elective procedures, addressing the shortage of doctors and improving surgical precision. The number of patients undergoing robot-assisted surgeries is expected to increase from 70,000 currently to 500,000 annually by 2035. Robotic technology, supported by advanced 3D vision and sensor systems such as Photoneo’s MotionCam-3D Color, is enhancing the capabilities of surgeons to perform minimally invasive operations with greater control and accuracy, even in challenging environments. The adoption of robots is anticipated to make them the default option for keyhole surgeries and expand their use in other surgical cases, potentially enabling nearly 3 million surgeries to be performed robotically to help cut NHS waiting times.

The Ramón y Cajal Hospital in Madrid has performed the first robot-assisted kidney transplant in the region. This procedure, developed by the hospital's Urology Service with collaboration from professionals at Barcelona's Bellvitge Hospital, uses robotic technology to reduce complications by being less invasive and providing greater precision. The advancement marks a notable step in surgical innovation within the Community of Madrid.

Intuitive Surgical Inc. reported its first-quarter 2025 earnings, surpassing analyst expectations. The company posted adjusted earnings per share (EPS) of $1.81, beating the estimated $1.71 to $1.73 range. Revenue reached $2.25 billion, exceeding estimates of approximately $2.18 billion to $2.19 billion and marking a 19% increase from $1.89 billion in the same quarter of 2024. GAAP net income attributable to Intuitive Surgical was $698 million, or $1.92 per diluted share, compared to $545 million, or $1.51 per diluted share, in the first quarter of 2024. The earnings beat aligns with a 76% beat rate observed in recent quarters, with an implied stock price move of around 7.1% following the announcement.

Cambridge-based CMR Surgical has successfully raised over €185 million (approximately $200 million) in funding to support its expansion into the U.S. market. The company, which specializes in developing surgical robotic systems for minimally invasive surgeries, aims to compete with the American giant Intuitive Surgical, valued at $180 billion. The funding round was backed by Trinity Capital, and the capital will be used to enhance the global reach of its Versius Surgical Robotic System. This investment reflects a growing confidence in the UK's life sciences sector, which is expected to create high-quality jobs.

Researchers at Johns Hopkins University have demonstrated a surgical robot capable of autonomously completing an entire gallbladder removal on ex-vivo pig organs. The system, named Surgical Robot Transformer-Hierarchy (SRT-H), was trained on about 17 hours of video covering 16,000 surgeon motions and uses a two-tier artificial-intelligence model to translate endoscopic images into plain-language instructions and then into precise tool movements.

Read more

In a pioneering medical procedure, Dr. Vipul Patel, based in Florida, successfully performed robotic prostate surgery on a 67-year-old patient located in Luanda, Angola, approximately 11,265 kilometers away. This operation, conducted as part of a human clinical trial approved by the U.S. Food and Drug Administration, marks the first transcontinental telesurgery of its kind in Africa.

The procedure utilized advanced robotic technology with no perceptible delay, demonstrating the potential to transform global healthcare access by enabling remote surgeries across vast distances. The patient, Fernando da Silva, was diagnosed with prostate cancer and discharged three days after the operation. This breakthrough follows recent developments in remote robotic surgeries, including Chinese surgeons performing satellite-powered liver surgeries over 5,000 kilometers away, highlighting rapid advancements in telesurgery facilitated by robotics and satellite communication technologies. Additionally, autonomous surgical robots trained with artificial intelligence have achieved 100% accuracy in complex procedures on lifelike models, signaling further innovation in surgical robotics.

In a pioneering medical procedure, Dr. Vipul Patel, based in Florida, successfully performed robotic prostate surgery on a patient located in Angola, approximately 11,265 kilometers away. This transcontinental telesurgery, conducted as part of a human clinical trial approved by the U.S. Food and Drug Administration, involved advanced robotic technology that enabled the operation with no perceptible delay.

The patient, Fernando da Silva, a 67-year-old man diagnosed with prostate cancer, was discharged three days after the procedure. This surgery marks the first of its kind globally and represents a potential breakthrough in expanding healthcare access through remote robotic-assisted surgeries. Separately, Chinese doctors have also recently achieved success in performing remote liver surgeries over a distance of 5,000 kilometers using satellite communication technology, demonstrating advancements in telesurgery beyond terrestrial networks. Healthcare experts are advocating for uniform insurance coverage for robotic-assisted surgeries to support these emerging medical technologies.

In a pioneering medical procedure, Dr. Vipul Patel, an Orlando-based surgeon, successfully performed robotic prostate surgery on a 67-year-old patient located in Angola, approximately 11,265 kilometers away. This transcontinental telesurgery, conducted under a human clinical trial approved by the U.S. Food and Drug Administration, marks the first instance of such a remote operation in Africa.

The patient, Fernando da Silva, was diagnosed with prostate cancer and underwent the procedure using advanced robotic technology that allowed for real-time control without delay. The surgery was completed successfully, and the patient was discharged after three days. This breakthrough demonstrates the potential of robotic telesurgery to expand access to specialized healthcare across global distances, potentially revolutionizing medical treatment in regions with limited surgical resources.

A Florida surgeon has completed what hospital officials say is the world’s longest-distance robotic operation, removing the prostate of a cancer patient in Luanda, Angola, from a console in Orlando, some 11,000 kilometres away. The 14 June procedure is the first remote surgery performed in Africa and is part of a U.S. Food and Drug Administration-approved clinical trial examining transcontinental telesurgery.

Read more

The National Health Service (NHS) in the UK is set to significantly expand the use of robotic-assisted surgery over the next decade, with projections indicating that 90% of all keyhole surgeries will be robot-assisted by 2035. This shift aims to reduce waiting times for elective procedures, addressing the shortage of doctors and improving surgical precision. The number of patients undergoing robot-assisted surgeries is expected to increase from 70,000 currently to 500,000 annually by 2035. Robotic technology, supported by advanced 3D vision and sensor systems such as Photoneo’s MotionCam-3D Color, is enhancing the capabilities of surgeons to perform minimally invasive operations with greater control and accuracy, even in challenging environments. The adoption of robots is anticipated to make them the default option for keyhole surgeries and expand their use in other surgical cases, potentially enabling nearly 3 million surgeries to be performed robotically to help cut NHS waiting times.

The Ramón y Cajal Hospital in Madrid has performed the first robot-assisted kidney transplant in the region. This procedure, developed by the hospital's Urology Service with collaboration from professionals at Barcelona's Bellvitge Hospital, uses robotic technology to reduce complications by being less invasive and providing greater precision. The advancement marks a notable step in surgical innovation within the Community of Madrid.

Intuitive Surgical Inc. reported its first-quarter 2025 earnings, surpassing analyst expectations. The company posted adjusted earnings per share (EPS) of $1.81, beating the estimated $1.71 to $1.73 range. Revenue reached $2.25 billion, exceeding estimates of approximately $2.18 billion to $2.19 billion and marking a 19% increase from $1.89 billion in the same quarter of 2024. GAAP net income attributable to Intuitive Surgical was $698 million, or $1.92 per diluted share, compared to $545 million, or $1.51 per diluted share, in the first quarter of 2024. The earnings beat aligns with a 76% beat rate observed in recent quarters, with an implied stock price move of around 7.1% following the announcement.

Cambridge-based CMR Surgical has successfully raised over €185 million (approximately $200 million) in funding to support its expansion into the U.S. market. The company, which specializes in developing surgical robotic systems for minimally invasive surgeries, aims to compete with the American giant Intuitive Surgical, valued at $180 billion. The funding round was backed by Trinity Capital, and the capital will be used to enhance the global reach of its Versius Surgical Robotic System. This investment reflects a growing confidence in the UK's life sciences sector, which is expected to create high-quality jobs.